Moreover, immune cells from mice bearing no or smaller tumors (mean tumor sizes; 0, 1 and 4 mm) produced dramatically higher levels of IFN-γ following stimulation with the HER2 class I peptides HER263–71 and HER2342–350 compared with the response to the control peptides. This evidence concerns the gene ERBB2 and neoplasm.